Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Evotec AG Total Assets 2010-2024 | EVO

Evotec AG total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
Evotec AG Annual Total Assets
(Millions of US $)
2023 $2,438
2022 $2,378
2021 $2,644
2020 $1,671
2019 $1,323
2018 $912
2017 $754
2016 $389
2015 $320
2014 $299
2013 $302
2012 $290
2011 $304
2010 $255
2009 $204
Evotec AG Quarterly Total Assets
(Millions of US $)
2024-09-30 $2,189
2024-06-30 $2,153
2024-03-31 $2,398
2023-09-30 $2,454
2023-06-30 $2,509
2022-12-31 $2,378
2022-09-30 $2,279
2022-06-30 $2,441
2022-03-31 $2,452
2021-12-31 $2,644
2021-09-30 $2,085
2021-06-30 $1,953
2021-03-31 $1,906
2020-12-31 $1,671
2020-09-30 $1,367
2020-06-30 $1,311
2020-03-31 $1,306
2019-12-31 $1,323
2019-09-30 $1,205
2019-06-30 $1,200
2019-03-31 $1,000
2018-12-31 $912
2018-09-30 $896
2018-06-30 $827
2018-03-31 $818
2017-12-31 $754
2017-09-30 $757
2017-06-30 $464
2017-03-31 $446
2016-12-31 $389
2016-09-30 $308
2016-06-30 $307
2016-03-31 $303
2015-12-31 $320
2015-09-30 $317
2015-06-30 $322
2015-03-31 $257
2014-12-31 $299
2014-09-30 $283
2014-06-30 $303
2014-03-31 $301
2013-12-31 $302
2013-09-30 $326
2013-06-30 $283
2013-03-31 $293
2012-12-31 $290
2012-09-30 $285
2012-06-30 $277
2012-03-31 $281
2011-12-31 $304
2011-09-30 $301
2011-06-30 $289
2011-03-31 $255
2010-12-31 $255
2010-09-30 $230
2010-06-30 $193
2010-03-31 $200
2009-12-31 $204
2009-09-30 $221
2009-06-30 $220
2009-03-31 $229
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.666B $0.846B
EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.557B 30.23
Chugai Pharmaceutical (CHGCY) Japan $73.258B 28.91
Takeda Pharmaceutical (TAK) Japan $43.305B 9.58
Sandoz Group AG (SDZNY) Switzerland $21.476B 0.00
Merck (MKKGY) Germany $19.083B 17.09
Astellas Pharma (ALPMY) Japan $16.957B 12.01
United Therapeutics (UTHR) United States $15.793B 15.54
Summit Therapeutics (SMMT) United States $15.243B 0.00
Neurocrine Biosciences (NBIX) United States $15.239B 45.75
Shionogi (SGIOY) Japan $12.318B 12.34
Orion OYJ (ORINY) Finland $7.466B 20.99
Madrigal Pharmaceuticals (MDGL) United States $7.203B 0.00
Corcept Therapeutics (CORT) United States $7.129B 54.00
Stevanato Group S.p.A (STVN) Italy $6.808B 44.08
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.911B 0.00
Ionis Pharmaceuticals (IONS) United States $5.152B 0.00
Grifols, S.A (GRFS) Spain $4.806B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.779B 9.78
Crinetics Pharmaceuticals (CRNX) United States $3.590B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.829B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.750B 12.47
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.469B 14.76
Centessa Pharmaceuticals (CNTA) United Kingdom $2.352B 0.00
Soleno Therapeutics (SLNO) United States $2.198B 0.00
Hypermarcas (HYPMY) Brazil $2.068B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.949B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.808B 0.00
Dyne Therapeutics (DYN) United States $1.706B 0.00
Indivior (INDV) United States $1.468B 5.98
Guardian Pharmacy Services (GRDN) United States $1.408B 0.00
Ardelyx (ARDX) United States $1.343B 0.00
ARS Pharmaceuticals (SPRY) United States $1.244B 0.00
Xencor (XNCR) United States $1.207B 0.00
Ocular Therapeutix (OCUL) United States $1.201B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.158B 0.00
Harrow (HROW) United States $1.105B 0.00
Enliven Therapeutics (ELVN) United States $1.098B 0.00
Collegium Pharmaceutical (COLL) United States $0.998B 5.45
Bioventus (BVS) United States $0.880B 27.80
Cronos Group (CRON) Canada $0.773B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.771B 0.00
Relay Therapeutics (RLAY) United States $0.755B 0.00
Verve Therapeutics (VERV) United States $0.708B 0.00
USANA Health Sciences (USNA) United States $0.595B 11.03
Elite Pharmaceuticals (ELTP) United States $0.556B 0.00
Xeris Biopharma Holdings (XERS) United States $0.540B 0.00
OmniAb (OABI) United States $0.524B 0.00
Altimmune (ALT) United States $0.491B 0.00
Savara (SVRA) United States $0.487B 0.00
ProKidney (PROK) United States $0.484B 0.00
KalVista Pharmaceuticals (KALV) United States $0.475B 0.00
Akebia Therapeutics (AKBA) United States $0.471B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.468B 0.00
Oruka Therapeutics (ORKA) United States $0.458B 0.00
Organogenesis (ORGO) United States $0.446B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.430B 174.21
Zevra Therapeutics (ZVRA) United States $0.421B 0.00
Siga Technologies (SIGA) United States $0.413B 4.82
Tourmaline Bio (TRML) United States $0.384B 0.00
Esperion Therapeutics (ESPR) United States $0.365B 0.00
Aldeyra Therapeutics (ALDX) United States $0.357B 0.00
Korro Bio (KRRO) United States $0.339B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.310B 0.00
4D Molecular Therapeutics (FDMT) United States $0.301B 0.00
CytoDyn (CYDY) United States $0.277B 0.00
Aquestive Therapeutics (AQST) United States $0.275B 0.00
Heron Therapeutics (HRTX) United States $0.272B 0.00
Nature's Sunshine Products (NATR) United States $0.271B 16.10
Amylyx Pharmaceuticals (AMLX) United States $0.257B 0.00
Innate Pharma SA (IPHYF) France $0.243B 0.00
Avita Medical (RCEL) United States $0.240B 0.00
Larimar Therapeutics (LRMR) United States $0.229B 0.00
MediWound (MDWD) Israel $0.210B 0.00
Acrivon Therapeutics (ACRV) United States $0.203B 0.00
Profound Medical (PROF) Canada $0.184B 0.00
Lexeo Therapeutics (LXEO) United States $0.179B 0.00
Aclaris Therapeutics (ACRS) United States $0.174B 0.00
Lyell Immunopharma (LYEL) United States $0.173B 0.00
Silence Therapeutics (SLN) United Kingdom $0.172B 0.00
Inhibikase Therapeutics (IKT) United States $0.169B 0.00
VAXART, INC (VXRT) United States $0.168B 0.00
Nanobiotix S.A (NBTX) France $0.166B 0.00
Champions Oncology (CSBR) United States $0.147B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.138B 0.00
Telomir Pharmaceuticals (TELO) United States $0.135B 0.00
Nektar Therapeutics (NKTR) United States $0.129B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
Cassava Sciences (SAVA) United States $0.113B 0.00
Achieve Life Sciences (ACHV) Canada $0.110B 0.00
ElectroCore (ECOR) United States $0.106B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.106B 0.00
Journey Medical (DERM) United States $0.104B 0.00
Inotiv (NOTV) United States $0.102B 0.00
Protara Therapeutics (TARA) United States $0.100B 0.00
Metagenomi (MGX) United States $0.099B 0.00
Pyxis Oncology (PYXS) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Avalo Therapeutics (AVTX) United States $0.085B 0.00
Regulus Therapeutics (RGLS) United States $0.083B 0.00
Karyopharm Therapeutics (KPTI) United States $0.083B 0.00
Galectin Therapeutics (GALT) United States $0.083B 0.00
Fractyl Health (GUTS) United States $0.077B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.20
ESSA Pharma (EPIX) Canada $0.075B 0.00
Mural Oncology (MURA) Ireland $0.075B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.075B 0.00
Nutriband (NTRB) United States $0.074B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Gain Therapeutics (GANX) United States $0.070B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.069B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Context Therapeutics (CNTX) United States $0.067B 0.00
Century Therapeutics (IPSC) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.063B 0.00
Prelude Therapeutics (PRLD) United States $0.061B 0.00
AleAnna (ANNA) United States $0.061B 0.00
OptiNose (OPTN) United States $0.060B 0.00
FibroGen (FGEN) United States $0.050B 0.00
AlloVir (ALVR) United States $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Rafael Holdings (RFL) United States $0.049B 0.00
SCYNEXIS (SCYX) United States $0.044B 0.00
CASI Pharmaceuticals (CASI) China $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
Incannex Healthcare (IXHL) Australia $0.039B 0.00
Surrozen (SRZN) United States $0.036B 0.00
VYNE Therapeutics (VYNE) United States $0.036B 0.00
BioVie (BIVI) United States $0.035B 0.00
Jupiter Neurosciences (JUNS) United States $0.034B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.031B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Traws Pharma (TRAW) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Scienture Holdings (SCNX) United States $0.029B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.024B 0.00
Vivos Therapeutics (VVOS) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Mannatech (MTEX) United States $0.022B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.021B 0.00
Carisma Therapeutics (CARM) United States $0.021B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.021B 0.00
Lipocine (LPCN) United States $0.020B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
Dominari Holdings (DOMH) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.007B 0.00
BioLineRx (BLRX) Israel $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
ProPhase Labs (PRPH) United States $0.006B 0.00
Clearmind Medicine (CMND) Canada $0.006B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.07
SHINECO (SISI) China $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Aditxt (ADTX) United States $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00